About

About

Levostar Biotech and Nucleus Biotech Announce Strategic Distribution Partnership


Levostar Biotech, a leading developer of innovative platforms for RNA therapeutics and advanced biologics, is pleased to announce a strategic partnership with Nucleus Biotech GmbH, a Germany-based life science distributor specializing in cutting-edge research tools. This collaboration will enable the distribution of Levostar’s RNA synthesis, plasmid production, and LNP delivery technologies across key European markets.
“Our partnership with Nucleus Biotech represents a significant step in making our RNA and nucleic acid technologies more accessible to the global research community,” said Xin Wu, CEO of Levostar Biotech. “Nucleus’s strong regional presence, deep scientific expertise, and trusted reputation among European researchers make them an ideal partner to accelerate our international growth.”
Through this alliance, Nucleus Biotech will integrate Levostar’s advanced product portfolio—including high-purity RNA reagents, plasmid services, and customizable mRNA synthesis—into its existing offering of genomic tools and next-generation sequencing technologies. 
“We are excited to bring Levostar’s cutting-edge solutions to our customers,” said Dr. Michael Ehret, Managing Director, at Nucleus Biotech GmbH. “By adding Levostar’s RNA platforms to our portfolio, we’re equipping scientists across Europe with powerful new tools for therapeutic discovery, development, and translational research. This collaboration strongly aligns with our mission to enable innovation in life sciences through access to best-in-class technologies.”
 

About Levostar Biotech

Levostar Biotech is a technology-driven enterprise specializing in RNA technologies. 

We provide innovative solutions for antibodies, cell and gene therapies, and nucleic acid-based drugs. 
 

About Nucleus Biotech GmbH

Headquartered in Heidelberg, Germany, Nucleus Biotech GmbH provides enabling reagents and services for life science research. 

Nucleus Biotech supports researchers across Europe with expert consultation and access to the latest scientific technologies.
 

For more information, please visit:
🌐 Levostar Biotech_Innovative Solutions for Innovative Therapies
🌐 Nucleus Biotech